共 26 条
- [25] Efficacy and safety of single- and repeated-selurampanel dosing for 2 weeks in patients with chronic subjective tinnitus: Results of a randomized, double-blind, placebo-controlled, cross-over, proof-of-concept phase IIa study TINNITUS - AN INTERDISCIPLINARY APPROACH TOWARDS INDIVIDUALIZED TREATMENT: FROM HETEROGENEITY TO PERSONALIZED MEDICINE, 2021, 260 : 423 - 440
- [26] An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-α2b in patients with multiple myeloma maintained on a steady dose of interferon-α2b ANNALS OF ONCOLOGY, 2007, 18 (08) : 1388 - 1394